Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
Modine Manufacturing
MOD
$11.1B
| $3.19M | ﹤0.01% |
302,906
+106,101
| +54% | +$1M |
|
4552
Kulicke & Soffa
KLIC
$5.19B
| $3.19M | ﹤0.01% |
74,412
+27,624
| +59% | +$1.37M |
|
|
SWTX
4553
DELISTED
SpringWorks Therapeutics
SWTX
| $3.19M | ﹤0.01% |
129,415
+102,516
| +381% | +$3.75M |
|
4554
PUT
Upwork
UPWK
$1.06B
| $3.19M | ﹤0.01% |
154,000
-2,600
| -2% | -$51.1K |
|
|
XM
4555
CALL
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $3.18M | ﹤0.01% |
254,300
-90,100
| -26% | -$1.6M |
|
4556
Adeia
ADEA
$3.29B
| $3.18M | ﹤0.01% |
833,070
+513,588
| +161% | +$2.15M |
|
4557
Rapid7
RPD
$876M
| $3.18M | ﹤0.01% |
47,570
-89,973
| -65% | -$7.43M |
|
4558
CALL
TG Therapeutics
TGTX
$7.46B
| $3.17M | ﹤0.01% |
746,900
+71,800
| +11% | +$448K |
|
|
DBD
4559
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.17M | ﹤0.01% |
1,398,078
+1,244,983
| +813% | +$4.64M |
|
|
KYCH
4560
DELISTED
Keyarch Acquisition Corporation Ordinary Shares
KYCH
| $3.17M | ﹤0.01% |
322,101
+1
| +0% | +$10 |
|
|
ZIMV
4561
DELISTED
ZimVie
ZIMV
| $3.17M | ﹤0.01% |
+197,996
| New | +$4.36M |
|
4562
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $3.17M | ﹤0.01% |
23,612
+15,997
| +210% | +$2.34M |
|
|
HZON
4563
DELISTED
Horizon Acquisition Corporation II
HZON
| $3.17M | ﹤0.01% |
319,702
-1,218,570
| -79% | -$12.1M |
|
4564
KKR & Co
KKR
$102B
| $3.16M | ﹤0.01% |
68,342
+5,777
| +9% | +$303K |
|
4565
CALL
Dine Brands
DIN
$447M
| $3.16M | ﹤0.01% |
48,600
-21,300
| -30% | -$1.52M |
|
4566
CALL
Cogent Communications
CCOI
$579M
| $3.16M | ﹤0.01% |
52,000
+14,400
| +38% | +$886K |
|
4567
PUT
Keurig Dr Pepper
KDP
$42.8B
| $3.16M | ﹤0.01% |
89,300
+46,800
| +110% | +$1.7M |
|
4568
CALL
SkinHealth Systems
SKIN
$86.8M
| $3.16M | ﹤0.01% |
245,600
+59,200
| +32% | +$793K |
|
4569
PUT
BioCryst Pharmaceuticals
BCRX
$2.49B
| $3.16M | ﹤0.01% |
298,300
-69,300
| -19% | -$715K |
|
4570
SPDR Gold Trust
GLD
$143B
| $3.15M | ﹤0.01% |
18,721
-946,178
| -98% | -$165M |
|
4571
Immunocore
IMCR
$1.76B
| $3.15M | ﹤0.01% |
84,500
+24,774
| +41% | +$805K |
|
4572
PUT
Stratasys
SSYS
$781M
| $3.15M | ﹤0.01% |
168,100
+500
| +0.3% | +$9.84K |
|
4573
PUT
Lamar Advertising Co
LAMR
$15.8B
| $3.15M | ﹤0.01% |
35,800
+24,100
| +206% | +$2.45M |
|
4574
TIM SA
TIMB
$8.29B
| $3.15M | ﹤0.01% |
258,944
+55,185
| +27% | +$753K |
|
4575
CALL
SandRidge Energy
SD
$520M
| $3.15M | ﹤0.01% |
200,700
+82,100
| +69% | +$1.64M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.